PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Respiratory Diseases Unit, Hopital d\'instruction des armées Sainte-Anne, Toulon, France.\', \'Division of Internal Medicine, Hopital d\'instruction des armées Sainte-Anne, Toulon, France. Electronic address: david.delarbre@yaho.fr.\', \'French Military Centre for Epidemiology and Public Health, and UMR 912 SESSTIM: INSERM-IRD-Université Aix-Marseille, Marseille, France.\', \'Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées, Brétigny sur Orge, France.\', \'9th Military Medical Centre, Toulon, France.\', \'Department of Education, Research and Innovation, French Defence Health Service, Paris, France.\', \'Charles de Gaulle Nuclear Aircraft Carrier, Toulon, France.\', \'Biology Unit, HIA Sainte-Anne, Toulon, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00707-410.1016/j.ijid.2021.09.002
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 34508860
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all